🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out the latest video for ICCS members discussing acute megakaryoblastic leukemia, transient abnormal myelopoiesis, and acute myeloid leukemia with RAM phenotype through a case-based approach. Link to video: cytometry.org/online/index.p… Interested in ICCS membership? It's a

Detection of CRLF2 expression by flow cytometry in B-ALL is a useful screening tool for identifying cases with CRLF2 rearrangements & for predicting JAK2 mutations. Check out this module from the ICCS Q&S Committee for tips on how to perform this assay: cytometry.org/web/modules/Mo…

#hemepath #molpath #leusm

It’s truly rewarding to watch our fantastic fellows, like Jorge (Jorge Chéverez), grow and shine throughout their fellowship. Grateful and excited to continue supporting them in my new role alongside our PD, Mike Michael A. Linden, MD, PhD 🤩 #hemepath #leusm #lymsm #mmsn #FlowEdu #PathX

ICCS has launched an all-new forum for members! The first channel discusses the new LDT regulations. Additional channels will be launched in the future. Go to the ICCS website and log in to access the forum: cytometry.org/web/index.php Interested in ICCS membership? It's a great

Celebrating the incredible tenure of Dr. John Manning at MD Anderson Cancer Center #hemepath 1978-2025 …. One of the very best lymphoma pathologist there ever was!!!

Minnesota #hemepath past, present and future @ the #socforhemepath reception @ #USCAP2025 Bartek Mehrnoosh Tashakori, MD PhD #flowedu #pathmatch2025

A proud mentor moment at #USCAP2025 😊 #hemepath #pathX #leusm #p53 #FlowEdu UMN Laboratory Medicine and Pathology UMN Medical School USCAP

One of the best things about #USCAP2025 is to see colleagues and friends! We all had a great time at the SocforHemepath reception! Enjoy the pictures 😉 #hemepath

Very excited to share our latest research article published with Springer Nature in Nature Communications. We show that in early #MDS, NK cells share mutations with the malignant clones, becoming dysfunctional and failing to eliminate aberrant stem cells. This leads to immune evasion and

I’m thrilled & proud to be the #Iranian 🇮🇷ambassador 4 Society of Hematologic Oncology (SOHO) I can sponsor 3 trainees (expenses covered). If you’re in Iran & like to attend #SOHO2025 pls submit an abstract (deadline: May 15) & contact me ASAP soho.click/abstract  soho.click/abstract-info #leusm

Congratulations Sharon Dent of MD Anderson Cancer Center, newly inducted #NASmember! #NAS162 #cancerresearch

Check out the latest module from the ICCS Q&S committee on automated sample preparation systems for clinical flow cytometry laboratories! This module provides detailed step-by-step instructions on how to select and validate these systems. Check it out here:

Happy hemepath fellowship Match Day! We’re excited to announce our new incoming fellows! Welcome to the UMN Hemepath family - we can’t wait to meet you in person and work with you! 😊 #hemepathmatch #hemepathmatch2026 Linnea Banker Michael A. Linden, MD, PhD Mehrnoosh Tashakori, MD PhD UMN Laboratory Medicine and Pathology

🚀 New Video Alert! Don't Miss It! 🚀 The ICCS Outreach Committee has released a new video focusing on the use of tandem dyes in flow cytometry. More videos coming soon, so please subscribe to our YouTube channel so you don't miss any! Watch it now at youtu.be/5cV7E9zzyLE?si…!

#FlowEdu

ICCS has revitalized their YouTube channel and will be releasing a range of #flowcytometry videos for all levels, from beginners to experts. The first video is on tandem dyes: youtube.com/watch?v=5cV7E9… Be sure to like and *subscribe* so that you don't miss new videos! #hemepath

Don't miss our upcoming webinar on Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms/Proliferations, on Monday, May 19th! Registration is free: cytometry.org/web/calendar.p…

Our ⁦MD Anderson Cancer Center⁩ experience Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort - ⁦Arch Pathol Lab Med⁩ #MRD #leusm #hemepath #AML pubmed.ncbi.nlm.nih.gov/40522873/

The most enduring marker of success isn't wealth, fame, or power. It’s what we create and contribute to others. In the short run, status symbols capture attention. In the long run, achievement is judged by impact. The highest accomplishment is improving the lives of others.